FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002809300> ?p ?o ?g. }

• W2002809300 endingPage "191" @default.
• W2002809300 startingPage "182" @default.
• W2002809300 abstract "BPR0C261 is a synthetic small molecule compound cytotoxic against human cancer cells and active prolonging the lifespan of leukemia mice. In the present study, we further investigated the mechanisms of its anticancer action and found that BPR0C261 inhibited microtubule polymerization through interacting with the colchicine binding sites on tubulins, disrupted microtubule arrangement and caused cell cycle arrest at G 2 /M phase in cancer cells. BPR0C261 also inhibited the clonogenic growths of cancer cells and showed cytotoxicity against human cervical cancer cells of multidrug‐resistant phenotype. In addition, BPR0C261 concentration‐dependently inhibited the proliferation and migration of HUVECs and disrupted the endothelial capillary‐like tube formations in HUVEC and rat aorta ring cultures. Given orally, BPR0C261 inhibited angiogenesis in s.c. implanted Matrigel plugs in mice. Notably, its IC 50 values against the endothelial cell growths were approximately 10‐fold lower than those against the cancer cells. It was found orally absorbable in mice and showed a good oral bioavailability (43%) in dogs. BPR0C261 permeated through the human intestinal Caco‐2 cell monolayer, suggesting oral availability in humans. Orally absorbed BPR0C261 distributed readily into the s.c. xenografted tumors in nude mice in which the tumor tissue levels of BPR0C261 were found oral dose‐dependent. BPR0C261 showed in vivo activities against human colorectal, gastric, and nasopharyngeal tumors in nude mice. Most interestingly, the combination of BPR0C261 plus cisplatin synergistically prolonged the lifespans of mice inoculated with murine leukemia cells. Thus, BPR0C261 is a novel orally active tubulin‐binding antitumor agent with antimitotic, apoptosis‐inducing, and vasculature disrupting activities. ( Cancer Sci 2011; 102: 182–191)" @default.
• W2002809300 created "2016-06-24" @default.
• W2002809300 creator A5001591873 @default.
• W2002809300 creator A5003446823 @default.
• W2002809300 creator A5012340999 @default.
• W2002809300 creator A5015435326 @default.
• W2002809300 creator A5015999780 @default.
• W2002809300 creator A5017230711 @default.
• W2002809300 creator A5021841162 @default.
• W2002809300 creator A5030284596 @default.
• W2002809300 creator A5055167905 @default.
• W2002809300 creator A5062911430 @default.
• W2002809300 creator A5063689491 @default.
• W2002809300 creator A5064785150 @default.
• W2002809300 creator A5066386967 @default.
• W2002809300 creator A5069131465 @default.
• W2002809300 creator A5070146210 @default.
• W2002809300 creator A5071717389 @default.
• W2002809300 creator A5072962127 @default.
• W2002809300 creator A5079606754 @default.
• W2002809300 creator A5082841536 @default.
• W2002809300 creator A5088399948 @default.
• W2002809300 creator A5089221624 @default.
• W2002809300 date "2010-10-12" @default.
• W2002809300 modified "2023-10-18" @default.
• W2002809300 title "BPR0C261 is a novel orally active antitumor agent with antimitotic and anti-angiogenic activities" @default.
• W2002809300 cites W1964481160 @default.
• W2002809300 cites W1965002318 @default.
• W2002809300 cites W1968785110 @default.
• W2002809300 cites W1981281946 @default.
• W2002809300 cites W1985099778 @default.
• W2002809300 cites W1988116079 @default.
• W2002809300 cites W2007570600 @default.
• W2002809300 cites W2015567783 @default.
• W2002809300 cites W2026509304 @default.
• W2002809300 cites W2032655930 @default.
• W2002809300 cites W2038298943 @default.
• W2002809300 cites W2038320131 @default.
• W2002809300 cites W2039220450 @default.
• W2002809300 cites W2046092556 @default.
• W2002809300 cites W2049313420 @default.
• W2002809300 cites W2055683699 @default.
• W2002809300 cites W2066128768 @default.
• W2002809300 cites W2071373120 @default.
• W2002809300 cites W2073970221 @default.
• W2002809300 cites W2080096359 @default.
• W2002809300 cites W2096254003 @default.
• W2002809300 cites W2098816850 @default.
• W2002809300 cites W2101878691 @default.
• W2002809300 cites W2115188495 @default.
• W2002809300 cites W2120863112 @default.
• W2002809300 cites W2130499442 @default.
• W2002809300 cites W2132742086 @default.
• W2002809300 cites W2140688970 @default.
• W2002809300 cites W2145516891 @default.
• W2002809300 cites W2148728305 @default.
• W2002809300 cites W2155176893 @default.
• W2002809300 cites W2157769714 @default.
• W2002809300 cites W2164195423 @default.
• W2002809300 cites W2170655985 @default.
• W2002809300 cites W2396933605 @default.
• W2002809300 cites W4230026896 @default.
• W2002809300 cites W4245635197 @default.
• W2002809300 doi "https://doi.org/10.1111/j.1349-7006.2010.01744.x" @default.
• W2002809300 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21040217" @default.
• W2002809300 hasPublicationYear "2010" @default.
• W2002809300 type Work @default.
• W2002809300 sameAs 2002809300 @default.
• W2002809300 citedByCount "11" @default.
• W2002809300 countsByYear W20028093002012 @default.
• W2002809300 countsByYear W20028093002013 @default.
• W2002809300 countsByYear W20028093002015 @default.
• W2002809300 countsByYear W20028093002018 @default.
• W2002809300 countsByYear W20028093002021 @default.
• W2002809300 countsByYear W20028093002022 @default.
• W2002809300 countsByYear W20028093002023 @default.
• W2002809300 crossrefType "journal-article" @default.
• W2002809300 hasAuthorship W2002809300A5001591873 @default.
• W2002809300 hasAuthorship W2002809300A5003446823 @default.
• W2002809300 hasAuthorship W2002809300A5012340999 @default.
• W2002809300 hasAuthorship W2002809300A5015435326 @default.
• W2002809300 hasAuthorship W2002809300A5015999780 @default.
• W2002809300 hasAuthorship W2002809300A5017230711 @default.
• W2002809300 hasAuthorship W2002809300A5021841162 @default.
• W2002809300 hasAuthorship W2002809300A5030284596 @default.
• W2002809300 hasAuthorship W2002809300A5055167905 @default.
• W2002809300 hasAuthorship W2002809300A5062911430 @default.
• W2002809300 hasAuthorship W2002809300A5063689491 @default.
• W2002809300 hasAuthorship W2002809300A5064785150 @default.
• W2002809300 hasAuthorship W2002809300A5066386967 @default.
• W2002809300 hasAuthorship W2002809300A5069131465 @default.
• W2002809300 hasAuthorship W2002809300A5070146210 @default.
• W2002809300 hasAuthorship W2002809300A5071717389 @default.
• W2002809300 hasAuthorship W2002809300A5072962127 @default.
• W2002809300 hasAuthorship W2002809300A5079606754 @default.
• W2002809300 hasAuthorship W2002809300A5082841536 @default.
• W2002809300 hasAuthorship W2002809300A5088399948 @default.
• W2002809300 hasAuthorship W2002809300A5089221624 @default.

• next